SUBSCRIBE
SUBSCRIBE

Gilead Sciences, Inc.

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Gilead Bets $125 Million on Spurring Investigational HIV Drug to Market
July 7, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Two Yale University Health Info Groups Sue FDA, Gilead for Hep C Drug Trial Data
June 30, 2015
 · 
5 min read
China Rejects Patent Linked To Gilead Hepatitis C Drug
June 22, 2015
 · 
1 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Receptos Allegedly Rebuffs AstraZeneca PLC Bid But Rivals Gilead, Teva are Circling
June 10, 2015
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Biotech Bay
Express Scripts Exec’s Elaborate Scheme to Load Up a Cruise Ship in India With Cheap Versions of Gilead Sovaldi
June 3, 2015
 · 
5 min read
Biowarfare Company Emergent's Cancer Spinoff Aptevo Therapeutics to Employ 70 - 90 in Seattle
Job Trends
Gilead Will Hire Up to 170 Scientists in $100 Million Edmonton Expansion
May 28, 2015
 · 
4 min read
Gilead’s Hep B Trial Failure Will Inspire M&A Activity, Say Analysts
Deals
Gilead’s Hep B Trial Failure Will Inspire M&A Activity, Say Analysts
May 28, 2015
 · 
7 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Gilead, GlobeImmune’s Hep B Drug Flunks Phase II Study
May 27, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
As Market Roars, Gilead Looking for “Value-Added” Deals, Says CFO
May 22, 2015
 · 
6 min read
Load More
  • 2025 BPTW Badge - RBG.png
  • 2024 Best Places to Work
  • 2023 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Biotech Bay
Gilead Sciences, Inc. Announces 43 Cents Quarterly Dividend Program And $15 Billion Share Buyback Program
February 4, 2015
 · 
1 min read
Business
Gilead Sciences, Inc. Announces Executive Promotions
January 29, 2015
 · 
1 min read
Business
Gilead Sciences, Inc. To Release Fourth Quarter And Full Year 2014 Financial Results On Tuesday, February 3, 2015
January 28, 2015
 · 
1 min read
Business
Envisionrx And Gilead Sciences, Inc. Sign Exclusive Agreement To Help In The Fight Against Hepatitis C
January 26, 2015
 · 
3 min read
Business
Mylan Inc. Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. To Include Investigational Pan-Genotypic Agent
January 26, 2015
 · 
4 min read
Business
Gilead Sciences, Inc. to Allow Generic Drugmakers to Produce New Hep C Drug
January 26, 2015
 · 
5 min read
Policy
After Gilead-AbbVie’s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next
January 23, 2015
 · 
3 min read
Biotech Bay
Gilead Sciences, Inc. To Present At The 33rd Annual J.P. Morgan Healthcare Conference On Tuesday, January 13
January 13, 2015
 · 
1 min read
Business
Ono Pharmaceutical Company, Ltd. And Gilead Sciences, Inc. Announce Exclusive License Agreement To Develop BTK Inhibitor, ONO-4059, For The Treatment Of B-Cell Malignancies And Other Diseases
December 19, 2014
 · 
1 min read
BioCapital
Biogen Idec And Gilead Sciences, Inc. Join The National Pharmaceutical Council
December 9, 2014
 · 
2 min read
Load More